AmerisourceBergen Performance

ABCDelisted Stock  USD 191.45  1.55  0.80%   
The firm shows a Beta (market volatility) of -0.0629, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning AmerisourceBergen are expected to decrease at a much lower rate. During the bear market, AmerisourceBergen is likely to outperform the market. AmerisourceBergen right now shows a risk of 0.0%. Please confirm AmerisourceBergen jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to decide if AmerisourceBergen will be following its price patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AmerisourceBergen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, AmerisourceBergen is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Begin Period Cash Flow3.1 B
Total Cashflows From Investing Activities-368.4 M
  

AmerisourceBergen Relative Risk vs. Return Landscape

If you would invest  19,145  in AmerisourceBergen on August 24, 2024 and sell it today you would earn a total of  0.00  from holding AmerisourceBergen or generate 0.0% return on investment over 90 days. AmerisourceBergen is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than AmerisourceBergen, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  

AmerisourceBergen Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for AmerisourceBergen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AmerisourceBergen, and traders can use it to determine the average amount a AmerisourceBergen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ABC
Based on monthly moving average AmerisourceBergen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AmerisourceBergen by adding AmerisourceBergen to a well-diversified portfolio.

AmerisourceBergen Fundamentals Growth

AmerisourceBergen Stock prices reflect investors' perceptions of the future prospects and financial health of AmerisourceBergen, and AmerisourceBergen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AmerisourceBergen Stock performance.

About AmerisourceBergen Performance

By analyzing AmerisourceBergen's fundamental ratios, stakeholders can gain valuable insights into AmerisourceBergen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AmerisourceBergen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AmerisourceBergen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AmerisourceBergen Corporation sources and distributes pharmaceutical products. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. Amerisourcebergen operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. It employs 000 people.

Things to note about AmerisourceBergen performance evaluation

Checking the ongoing alerts about AmerisourceBergen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AmerisourceBergen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AmerisourceBergen is not yet fully synchronised with the market data
AmerisourceBergen has a very high chance of going through financial distress in the upcoming years
AmerisourceBergen has 5.7 B in debt. AmerisourceBergen has a current ratio of 0.89, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AmerisourceBergen to invest in growth at high rates of return.
Over 79.0% of the company shares are held by institutions such as insurance companies
Evaluating AmerisourceBergen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate AmerisourceBergen's stock performance include:
  • Analyzing AmerisourceBergen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AmerisourceBergen's stock is overvalued or undervalued compared to its peers.
  • Examining AmerisourceBergen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating AmerisourceBergen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AmerisourceBergen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of AmerisourceBergen's stock. These opinions can provide insight into AmerisourceBergen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating AmerisourceBergen's stock performance is not an exact science, and many factors can impact AmerisourceBergen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in AmerisourceBergen Stock

If you are still planning to invest in AmerisourceBergen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AmerisourceBergen's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk